farnesyl-pyrophosphate and Chronic-Disease

farnesyl-pyrophosphate has been researched along with Chronic-Disease* in 1 studies

Other Studies

1 other study(ies) available for farnesyl-pyrophosphate and Chronic-Disease

Article	Year
Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling. American journal of physiology. Lung cellular and molecular physiology, 2016, 11-01, Volume: 311, Issue:5 Topics: Animals; Animals, Newborn; Biosynthetic Pathways; Blood Pressure; Cholesterol; Chronic Disease; Female; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Male; Myelin Sheath; Nitric Oxide Synthase Type III; Organ Size; Physical Conditioning, Animal; Polyisoprenyl Phosphates; Pulmonary Artery; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Sesquiterpenes; Signal Transduction; Simvastatin; Vascular Remodeling	2016

Article

Year

Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.

American journal of physiology. Lung cellular and molecular physiology, 2016, 11-01, Volume: 311, Issue:5

Topics: Animals; Animals, Newborn; Biosynthetic Pathways; Blood Pressure; Cholesterol; Chronic Disease; Female; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Male; Myelin Sheath; Nitric Oxide Synthase Type III; Organ Size; Physical Conditioning, Animal; Polyisoprenyl Phosphates; Pulmonary Artery; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Sesquiterpenes; Signal Transduction; Simvastatin; Vascular Remodeling

2016